Belay Diagnostics logo
  • Tests
    • Overview
    • Summit™ 2.0
    • Ascent™
    • Vantage™
  • Clinicians
    • HOW TO ORDER
    • Join Us at SNO2026
    • Our Tests
    • Publications
    • Belay Portal
    • CSF Sample Handling
    • Ordering and Billing FAQs
    • Test Requisition Form
    • Sample Test Reports
    • Case Studies
    • Contact Us
  • Patients
    • Summit™ and Vantage™ for Patients
    • Patient FAQs
    • Contact Us
  • Laboratorians
    • Overview
    • Our Tests
    • CSF Sample Handling
    • Publications
    • Test Requisition Form
    • Sample Test Reports
    • Contact Us
  • Resources
    • Publications
    • Latest News
    • Conferences We Attend
    • Belay Portal
    • Contact Us
  • About
    • Company
    • Mission, Vision and Values
    • Latest News
    • Licenses
    • Careers
    • Compliance Hotline
    • Contact Us
  • Tests
    • Overview
    • Summit™ 2.0
    • Ascent™
    • Vantage™
  • Clinicians
    • HOW TO ORDER
    • Join Us at SNO2026
    • Our Tests
    • Publications
    • Belay Portal
    • CSF Sample Handling
    • Ordering and Billing FAQs
    • Test Requisition Form
    • Sample Test Reports
    • Case Studies
    • Contact Us
  • Patients
    • Summit™ and Vantage™ for Patients
    • Patient FAQs
    • Contact Us
  • Laboratorians
    • Overview
    • Our Tests
    • CSF Sample Handling
    • Publications
    • Test Requisition Form
    • Sample Test Reports
    • Contact Us
  • Resources
    • Publications
    • Latest News
    • Conferences We Attend
    • Belay Portal
    • Contact Us
  • About
    • Company
    • Mission, Vision and Values
    • Latest News
    • Licenses
    • Careers
    • Compliance Hotline
    • Contact Us
Contact Us
We are currently experiencing technical issues with our phone system. For immediate assistance, please email us at contact@belaydiagnostics.com. We apologize for the inconvenience.​

About Belay Diagnostics

  • Where to Meet Belayers – Conferences
  • Belay Mission, Vision and Values
  • Document Library

Clinician Resources

  • Summit™ 2.0 and Vantage™ for Clinicians
  • Clinician Test Ordering and Billing FAQs
  • Sample Test Reports
  • 2024 SNO ASCO Webinar ​
  • CSF Sample Handling
  • Belay Summit™ Patient Case Studies Using Summit 1.0
  • 2025 SNO ASCO Webinar – CSF Tumor DNA Biomarker​
  • Test Requisition Form
  • 2025 SNO Scientific Presentations

Patient Resources

  • Patient FAQs
  • Summit™ 2.0 and Vantage™ for Patients

Shipping and Logistics

  • Belay Diagnostics Supplies
  • Specimen Collecting, Packing and Shipping

Advocacy and Support

  • Brain and Spinal Cord Tumor Organizations

Connect with Us

  • Contact and Support
  • HCP Inquiries
  • Patient Inquiries
  • Home
  • Docs
  • Clinician Resources
  • Sample Test Reports

Sample Test Reports

Tap or click on the images below to view, download, or print sample test reports.

Glioblastoma (GBM)

Sample Summit 2.0, Ascent, and Vantage cerebrospinal fluid liquid biopsy report showing a positive result for glioblastoma, with EGFR, PIK3CA, and TERT mutations, CDK4 and MDM2 amplifications, chromosome 7 gain and chromosome 10 loss, a chr7p11.2 gain, and MGMT methylation detected.
Belay Summit 2.0, Ascent & Vantage Report – Positive GBM
Sample Summit 2.0 and Ascent cerebrospinal fluid liquid biopsy report showing a positive result for glioblastoma, with chromosome 7 gain, chromosome 10 loss, and a chr7p11.2 gain containing EGFR detected by Ascent and no clinically significant variants detected by Summit.
Belay Summit 2.0 (Negative) & Ascent (Positive) Report – GBM
Sample Ascent cerebrospinal fluid liquid biopsy report showing a positive result for glioblastoma, with chromosome 7 gain, chromosome 10 loss, and a chr7p11.2 gain containing EGFR detected.
Belay Ascent (Positive) Report – GBM

Oligodendroglioma

Sample Summit 2.0, Ascent, and Vantage cerebrospinal fluid liquid biopsy report showing a positive result for oligodendroglioma, with IDH1 R132H and CIC mutations, 1p/19q codeletion, and MGMT methylation detected.
Belay Summit 2.0, Ascent & Vantage Report – Positive Oligodendroglioma

Primary CNS Lymphoma (PCNSL)

Sample Summit 2.0 and Vantage cerebrospinal fluid liquid biopsy report showing a positive result for central nervous system lymphoma, with CD79B, MYD88, and ETV6 mutations and MGMT methylation detected, along with a chart showing decreasing variant allele fractions over time.
Belay Summit 2.0 & Vantage Report – Positive PCNSL
Sample Summit 2.0, Ascent, and Vantage cerebrospinal fluid liquid biopsy report showing a positive result for central nervous system lymphoma, with CD79B, MYD88, and ETV6 mutations and MGMT methylation detected, along with a chart showing decreasing variant allele fractions over time.
Belay Summit 2.0 (Negative), Ascent (Negative) & Vantage (Positive) Report – PCNSL

Brain Metastases – Breast

Sample Summit 2.0 and Ascent cerebrospinal fluid liquid biopsy report showing a positive result for metastatic breast carcinoma, with ERBB2 amplification and CDH1 and PIK3CA mutations detected.
Belay Summit 2.0 & Ascent Report – Positive Brain Metastases

Brain Metastases – Lung

Sample Summit 2.0 and Ascent cerebrospinal fluid liquid biopsy report showing a positive result for metastatic lung adenocarcinoma, with EGFR L858R and L62R, FANCA, and KMT2A mutations, MDM2 amplification, and high tumor mutational burden detected, along with charts showing increasing variant levels over time.
Belay Summit 2.0 & Ascent Report – Positive Lung Metastases

Central Nervous System Neoplasm (Unspecified/General)

Sample Summit 2.0 and Ascent cerebrospinal fluid liquid biopsy report showing a positive result for medulloblastoma, with an ARID1A mutation, chromosome 17p loss, and chromosome 17q gain detected.
Belay Summit 2.0 & Ascent Report – Medulloblastoma Positive CNS – Pediatric
Sample Summit 2.0, Ascent, and Vantage cerebrospinal fluid liquid biopsy report showing a negative result for a central nervous system neoplasm, with no clinically significant variants detected and MGMT unmethylated.
Belay Summit 2.0, Ascent & Vantage Report – Negative CNS
Sample Summit 2.0 and Ascent cerebrospinal fluid liquid biopsy report showing a positive result for glioma, with H3-3A K28M (H3 K27M) and TP53 mutations characteristic of diffuse midline glioma, H3 K27-altered, detected.
Belay Summit 2.0 (Positive) & Ascent (Negative) Report – CNS
Sample Summit 2.0 cerebrospinal fluid liquid biopsy report showing a positive result for astrocytoma, with a KIAA1549::BRAF fusion and two BCOR mutations detected.
Belay Summit 2.0 Report – Astrocytoma Positive CNS – Pediatric
Share Article
  • Facebook
  • X
  • LinkedIn

Belay Diagnostics
1375 W. Fulton St. Ste 530
Chicago, IL 60607 USA

Privacy Practices    Privacy Policy    Terms of Use

contact@belaydiagnostics.com
Phone: +1 (331) 320-0155
Fax: +1 (800) 501-9246

© 2026 Belay Diagnostics. All Rights Reserved.
X-twitter Facebook Instagram Linkedin